Condition

Secondary Prevention clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Secondary Prevention clinical trials that are recruiting, at sites in 3 countries (most in China (1), South Korea (1), Norway (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Secondary Prevention clinical trials

StudyPhaseWhereStatusRegistered
Comparing 50 mg and 100 mg daily aspirin for older adults with cardiovascular disease — Beijing Recruiting Apr 21, 2026
Post-stroke heart rhythm monitoring with a wearable chest patch in Southern Norway — Kristiansand Recruiting Feb 12, 2026
Determining the best LDL cholesterol levels for small vessel occlusion stroke prevention — Ansan and 45 other locations Recruiting Oct 18, 2024

All recruiting trials (3)

Related topics

Cardiovascular DiseasesIschemic StrokeAtherosclerotic Cardiovascular Disease (ASCVD)Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)Small Vessel Cerebrovascular Disease

Quick answers

How many Secondary Prevention clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (1 trial), South Korea (1 trial), Norway (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.